Loading clinical trials...
Loading clinical trials...
Safety and Effectiveness of the CellFX® nsPFA Catheter Endocardial Ablation System for the Treatment of Paroxysmal Atrial Fibrillation
Conditions
Interventions
CellFX nsPFA Cardiac Catheter System
Locations
1
Czechia
Na Homolce Hospital
Prague, Roentgenova, Czechia
Start Date
January 1, 2026
Primary Completion Date
October 1, 2026
Completion Date
January 1, 2027
Last Updated
December 24, 2025
NCT06557876
NCT06096246
NCT06854081
NCT07020910
NCT06898307
NCT06282393
Lead Sponsor
Pulse Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions